• Aucun résultat trouvé

Accelerated immune senescence in HIV infection

N/A
N/A
Protected

Academic year: 2021

Partager "Accelerated immune senescence in HIV infection"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: inserm-00664019

https://www.hal.inserm.fr/inserm-00664019

Submitted on 28 Jan 2012

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Accelerated immune senescence in HIV infection

Victor Appay

To cite this version:

Victor Appay. Accelerated immune senescence in HIV infection. 16th International Symposium on

HIV and Emerging Infectious Diseases, Mar 2010, Marseille, France. pp.I30,

�10.1186/1742-4690-7-S1-I30�. �inserm-00664019�

(2)

I N V I T E D S P E A K E R P R E S E N T A T I O N

Open Access

Accelerated immune senescence in HIV infection

Victor Appay

From 16

th

International Symposium on HIV and Emerging Infectious Diseases

Marseille, France. 24-26 March 2010

Aim

The prospect that immune activation or inflammation may be directly related to the increased incidence in HIV infected donors of manifestations that are reminis-cent of the human aging process (i.e. cardiovascular dis-ease, malignancies, osteoporosis, cognitive impairment, depression and frailty) is raising increasing concerns. On the immunological side, in addition to promoting viral replication as well as CD4+ T cell apoptosis, HIV asso-ciated immune activation may also lead to an acceler-ated decline of immune competence resembling the phenomenon of immunosenescence. Our aim is to explore further the potential relationship between immune activation, HIV disease progression and immunosenescence.

Materials and methods

We performed a comparative analysis of immunologic markers in different groups of HIV infected donors and healthy controls. The initial investigation of blood lym-phocyte populations led us rapidly to turn our attention onto the lymphocyte primary immune resources, i.e. the CD34+ hematopoietic progenitor cells (studied directly from the blood of patients).

Results

Human aging and HIV-1 infection exhibit a number of parallels with regards to immunological attributes, that are evocative of premature immunosenescence in HIV-1 infected patients and reflect a reduced production of lymphocytes. Analyses of CD34+ hematopoietic progeni-tor cell number, phenotype and clonogenic potential underline a manifest impairment of primary immune resources with age or HIV-1 infection. Systemic immune activation emerges as a major correlate of altered lym-phopoiesis, which can be partially reversed with pro-longed antiretroviral therapy. Poor CD4+ T cell count

recovery despite successful virological response on anti-retroviral treatment is associated with persistent damage to the lymphopoietic system.

Discussion

Our findings provide new insights into the consequences of persistent immune activation in HIV-1 infection, and demonstrate the importance of primary hematopoietic resources in HIV pathogenesis and the response to antiretroviral treatments, but also more generally in the development of immunosenescence.

Published: 11 May 2010

doi:10.1186/1742-4690-7-S1-I30

Cite this article as: Appay: Accelerated immune senescence in HIV infection. Retrovirology 2010 7(Suppl 1):I30.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

Infections and Immunity, INSERM UMR S 945, Faculté de Médicine, Hôpital Pitié-Salpétrière, 91 Bd de l’Hôpital, 75013 Paris, France

Appay Retrovirology 2010, 7(Suppl 1):I30 http://www.retrovirology.com/content/7/S1/I30

Références

Documents relatifs

Experimental results for CD4+ guided structured treatment interruptions CD4+ count limits [cells/µl] Simulation results (~ 10 years) Clinical study Interruption Resumption

The HLA-B, HLA-C and KIR genetic profiles were deter- mined from 162 individuals divided into four groups as follows: Group 1 - individuals infected with HIV-1 and

Le lendemain, les trois amis arrivent avec leurs vélos, vêtus de vieux habits, pour la plupart élimés voire déchirés, s’arrêtent devant le portail de la maison

Il faut savoir que j’étais seul à la maison et je n’avais aucune autre solution que d’affronter cette situation personnellement.. Mon visage était mouillé et

Bientôt, les cinq hommes se figèrent sur place chacun leur tour et ressentirent progressivement en leur corps d'extrêmes souffrances qu’ils ne purent réprimer avant de

Parmi les dix secteurs du ter- tiaire qui emploient plus de 30 % de jeunes actifs en mars 2002, la moitié sont à haute qualification de l’emploi : les activités de télé-

 ISSEA, Institut Sous-régional de Statistique et d'Économie Appliquée de Yaoundé  ENSAE, École Nationale de la Statistique et de l'Analyse Économique de Dakar  ENEAM,

equation (2) shows that both T~ cells as well as viral populations continues to increase within the limit of our time steps (10~) for all values of initial cellular concentrations